Martin Riegler

<i>Saccharomyces boulardii</i> Protease Inhibits the Effects of <i>Clostridium difficile</i> Toxins A and B in Human Colonic Mucosa

Ignazio Castagliuolo, Martin Riegler, Leyla Valenick et al. · Infection and Immunity · 1999 · 395 citations · Full text

Life Sciences, Immunology, Microbiology +17

Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.

Martin Riegler, Roland Sedivy, Charalabos Pothoulakis et al. · Journal of Clinical Investigation · 1995 · 345 citations · Full text

Life Sciences, Pathobiology, Mechanisms Of Toxicity +13

Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation

Sang Hoon Rhee, Eunok Im, Martin Riegler et al. · Proceedings of the National Academy of Sciences · 2005 · 226 citations · Full text

Life Sciences, Immunology, Microbiology +17

Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis.

Ignazio Castagliuolo, Martin Riegler, Asiya Pasha et al. · Journal of Clinical Investigation · 1998 · 177 citations · Full text

Veterinary Medicine, Immunology, Pathology +17

The antifungal antibiotic, clotrimazole, inhibits chloride secretion by human intestinal T84 cells via blockade of distinct basolateral K+ conductances. Demonstration of efficacy in intact rabbit colon and in an in vivo mouse model of cholera.

Paul A. Rufo, Didier Merlin, Martin Riegler et al. · Journal of Clinical Investigation · 1997 · 117 citations · Full text

Life Sciences, Pharmacology, Physiology +17